From pharmacokinetics to pharmacogenomics: a new approach to tailor immunosuppressive therapy.
about
Human pharmacogenomic variations and their implications for antifungal efficacy.Pharmacokinetic principles of immunosuppressive drugs.Pharmacogenetic differences and drug-drug interactions in immunosuppressive therapy.Pharmacogenetics of immunosuppressants: progress, pitfalls and promises.Influence of ABCB1 polymorphisms and haplotypes on tacrolimus nephrotoxicity and dosage requirements in children with liver transplant.Pharmacogenetic considerations for optimizing tacrolimus dosing in liver and kidney transplant patientsCYP3A polymorphisms and immunosuppressive drugs in solid-organ transplantation.Drug choices in autoimmune hepatitis: part B--Nonsteroids.Pharmacokinetic consideration of synthetic DMARDs in rheumatoid arthritis.Pharmacogenetics of posttransplant diabetes mellitus.Influence of CYP3A5 6986A > G and ABCB1 3435C > T Polymorphisms on Adverse Events Associated With Tacrolimus in Jordanian Pediatric Renal Transplant Patients.Tacrolimus and sirolimus induce reproductive abnormalities in female rats.Using genetic and clinical factors to predict tacrolimus dose in renal transplant recipients.C-440T/T-331C polymorphisms in the UGT1A9 gene affect the pharmacokinetics of mycophenolic acid in kidney transplantation.
P2860
Q35070838-741AFEC7-6723-43AC-ABC4-877A2ABCB989Q36006086-2376B8DD-F295-450A-A3F0-27F99AB5E4F2Q36544981-01EBD3F2-9D38-4E3D-A74A-24F7AD26D803Q37176567-DA99BE34-D4A5-4EE9-BF83-0938265AC8EBQ37397805-E2B4E1B2-902F-43AB-862A-1DF24A9AB68FQ37439873-5646A88C-06D4-4630-9689-E12AC7BC23A2Q37478703-E4980030-8EDD-43ED-A61B-8A6741F3BEAEQ38051706-A9BC0588-3446-473C-B6FD-AC8B32E5C0C3Q38097969-7C7A7A74-61E3-4C3F-8B48-AA672328B6ADQ39204562-10D4EBAD-5F41-488D-BE37-3E8A7322A392Q39816513-4EECC894-261A-4C57-9966-436E0555459CQ41718697-08A54F9A-7880-469B-9DDD-0728D6186820Q42837771-8C23B218-BFBA-49F2-966F-66A098D995FCQ46959473-0296DDD2-1FBE-4E24-83EF-42A4064C0474
P2860
From pharmacokinetics to pharmacogenomics: a new approach to tailor immunosuppressive therapy.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
From pharmacokinetics to pharm ...... lor immunosuppressive therapy.
@ast
From pharmacokinetics to pharm ...... lor immunosuppressive therapy.
@en
type
label
From pharmacokinetics to pharm ...... lor immunosuppressive therapy.
@ast
From pharmacokinetics to pharm ...... lor immunosuppressive therapy.
@en
prefLabel
From pharmacokinetics to pharm ...... lor immunosuppressive therapy.
@ast
From pharmacokinetics to pharm ...... lor immunosuppressive therapy.
@en
P2860
P1476
From pharmacokinetics to pharm ...... lor immunosuppressive therapy.
@en
P2093
Norberto Perico
P2860
P304
P356
10.1111/J.1600-6143.2004.00312.X
P407
P577
2004-03-01T00:00:00Z